Death man in AstraZeneca and Oxford vaccine study ‘received placebo’ Abroad

That reports the German newspaper Bild.

The National Agency for Health Supervision (Anvisa) announced on Wednesday that a 28-year-old doctor had died while testing a new vaccine. A spokesperson for AstraZeneca Netherlands confirmed the death, but did not want to say anything else.

Brazilian media speculate according to Bild that the doctor would have died of corona.

In drug studies, some of the participants are always given an ineffective drug (placebo).

The Brazilian’s death does not lead to an end to trials of the vaccine, Anvisa spokesman said. “All major medical events have been carefully reviewed by investigators, an independent committee and the authorities. This does not reveal any concerns about the progress of the investigation. ”

“Exemplary doctor”

According to the Brazilian O Globo, this is the young doctor João Pedro R. Feitosa, former medical student at the Federal University of Rio de Janeiro. That institution has issued a letter of condolence. Feitosa has been called an ‘exemplary doctor and student’. “The emptiness and the loss are increasing every moment. What gives us strength at the moment is how you were. ”

Shut down

Earlier, the research was halted when one of the subjects turned out to have a disease of the spinal cord. The study continued after a short break. There was no demonstrable relationship with the vaccine.

The Netherlands and other European countries have previously ordered 300 million doses from AstraZeneca, which will be purchased once the vaccine has actually proven itself. The vaccine is currently being tested in the United Kingdom, South Africa, Brazil and India.

–